Rationale: The pathophysiological changes in respiratory muscle morphology and functioning in patients with end-stage pulmonary disease are not very well known. Furthermore, in COPD, long-term high-intensity NIV is applied without knowing the exact consequences on the lungs and respiratory muscles. Objective: The aims of the study are to get insight in: A. changes respiratory muscles in end-stage respiratory disease, comparing COPD with restrictive lung disease (RLD) due to pulmonary fibrosis B. the effects of long-term HI-NIV in severe COPD patients on the respiratory muscles and the lungs; by comparing COPD patients that had been treated with long-term NIV to COPD patients that were not treated with long-term NIV. Study design: In order to investigate this, the investigators will include in a small pilot cohort study patients being lung transplanted. In these patients there is lung tissue available and respiratory muscle biopsies will be performed during lung-transplant surgery. Study population: Patients that are listed for lung transplantation for an underlying diagnosis of COPD or RLD will be asked to participate. Three groups will be included: patients with a RLD due to pulmonary fibrosis, COPD patients that had been treated with long-term NIV prior to being lung transplanted and COPD patients that were not treated with long-term NIV. Patients will be included definitely once being lung transplanted. Main study parameters/endpoints: The study is an exploratory pilot study. Both contractile strength and the structure of single diaphragm and intercostal muscle fibres as well as lung injury; i.e. alveolar structure and damage and inflammation in the alveoli, will be investigated.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Respiratory muscle morphology and functioning
Timeframe: during surgery
Ventilator-associated lung injury serum TNF-alfa
Timeframe: during surgery
Ventilator-associated lung injury serum IL-6
Timeframe: during surgery
Ventilator-associated lung injury serum IL-1beta
Timeframe: during surgery
Ventilator-associated lung injury serum IL-8
Timeframe: during surgery
Ventilator-associated lung injury serum MIP-2
Timeframe: during surgery
Ventilator-associated lung injury serum sRAGE
Timeframe: during surgery
Ventilator-associated lung injury BAL TNF-alfa
Timeframe: during surgery
Ventilator-associated lung injury BAL IL-6
Timeframe: during surgery
Ventilator-associated lung injury BAL IL-1beta
Timeframe: during surgery
Ventilator-associated lung injury BAL IL-8
Timeframe: during surgery
Ventilator-associated lung injury BAL MIP-2
Timeframe: during surgery
Ventilator-associated lung injury BAL sRAGE
Timeframe: during surgery
Ventilator-associated lung injury basal membrane
Timeframe: during surgery
Ventilator-associated lung injury alveolar cells
Timeframe: during surgery
Ventilator-associated lung injury edema
Timeframe: during surgery
Ventilator-associated lung injury fibrin
Timeframe: during surgery
Ventilator-associated lung injury inflammatory cells
Timeframe: during surgery
Ventilator-associated lung injury gene-expression
Timeframe: during surgery